跳至主要内容
临床试验/NCT05486247
NCT05486247已完成不适用

Molecular Characterization of Gliomas Using a Broad NGS Panel

Hellenic Cooperative Oncology Group0 个研究点目标入组 32 人开始时间: 2015年2月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
32
主要终点
The prevalence of genetic alterations in patients with high grade glioma using a 80 gene NGS panel

研究概览

简要总结

Gliomas are the most common malignant primary brain tumors with poor prognosis. The genotyping of tumors using NGS platforms enables the identification of genetic alterations that constitute diagnostic, prognostic and predictive biomarkers.Here in, we investigated the molecular profile of 32 tumor samples from 32 patients with high grade gliomas by implementing a broad 80-gene targeted NGS panel while reporting their clinicopathological characteristics and outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of high grade glioma based on tissue biopsy

排除标准

  • 未提供

结局指标

主要结局

The prevalence of genetic alterations in patients with high grade glioma using a 80 gene NGS panel

时间窗: April 2019 - December 2021

The prevalence of genetic alterations in patients with high grade glioma using a 80 gene NGS panel

次要结局

未报告次要终点

研究者

发起方
Hellenic Cooperative Oncology Group
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rania Romanidou

Dr Ourania Romanidou

Hellenic Cooperative Oncology Group

相似试验

Molecular Characterization of Gliomas Using a Broad... | 临床试验